Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection

Background: Zinc is an essential micronutrient that impacts host–pathogen interplay at infection. Zinc balances immune responses, and also has a proven direct antiviral action against some viruses. Importantly, zinc deficiency (ZD) is a common condition in elderly and individuals with chronic diseas...

Full description

Bibliographic Details
Main Authors: Marina Vogel-González, Marc Talló-Parra, Víctor Herrera-Fernández, Gemma Pérez-Vilaró, Miguel Chillón, Xavier Nogués, Silvia Gómez-Zorrilla, Inmaculada López-Montesinos, Isabel Arnau-Barrés, Maria Luisa Sorli-Redó, Juan Pablo Horcajada, Natalia García-Giralt, Julio Pascual, Juana Díez, Rubén Vicente, Robert Güerri-Fernández
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/13/2/562
id doaj-0c7797c8549b44c6a8f628be89745449
record_format Article
spelling doaj-0c7797c8549b44c6a8f628be897454492021-02-10T00:00:05ZengMDPI AGNutrients2072-66432021-02-011356256210.3390/nu13020562Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 InfectionMarina Vogel-González0Marc Talló-Parra1Víctor Herrera-Fernández2Gemma Pérez-Vilaró3Miguel Chillón4Xavier Nogués5Silvia Gómez-Zorrilla6Inmaculada López-Montesinos7Isabel Arnau-Barrés8Maria Luisa Sorli-Redó9Juan Pablo Horcajada10Natalia García-Giralt11Julio Pascual12Juana Díez13Rubén Vicente14Robert Güerri-Fernández15Laboratory of Molecular Physiology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, 08003 Barcelona, SpainMolecular Virology Group, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, 08003 Barcelona, SpainLaboratory of Molecular Physiology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, 08003 Barcelona, SpainMolecular Virology Group, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, 08003 Barcelona, SpainDepartment of Biochemistry and Molecular Biology and Institute of Neurosciences, Edifici H, Universitat Autònoma de Barcelona, 08193 Bellaterra, SpainDepartment of Internal Medicine, Hospital del Mar, Institut Mar d’Investigacions Mediques, 08003 Barcelona, SpainDepartment of Infectious Diseases, Hospital del Mar, Institut Mar d’Investigacions Mediques, 08003 Barcelona, SpainDepartment of Infectious Diseases, Hospital del Mar, Institut Mar d’Investigacions Mediques, 08003 Barcelona, SpainDepartment of Infectious Diseases, Hospital del Mar, Institut Mar d’Investigacions Mediques, 08003 Barcelona, SpainDepartment of Infectious Diseases, Hospital del Mar, Institut Mar d’Investigacions Mediques, 08003 Barcelona, SpainDepartment of Infectious Diseases, Hospital del Mar, Institut Mar d’Investigacions Mediques, 08003 Barcelona, SpainDepartment of Internal Medicine, Hospital del Mar, Institut Mar d’Investigacions Mediques, 08003 Barcelona, SpainDepartment of Nephrology, Hospital del Mar, Institut Mar d’Investigacions Mediques, Autonomous University of Barcelona, 08003 Barcelona, SpainMolecular Virology Group, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, 08003 Barcelona, SpainLaboratory of Molecular Physiology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, 08003 Barcelona, SpainDepartment of Infectious Diseases, Hospital del Mar, Institut Mar d’Investigacions Mediques, 08003 Barcelona, SpainBackground: Zinc is an essential micronutrient that impacts host–pathogen interplay at infection. Zinc balances immune responses, and also has a proven direct antiviral action against some viruses. Importantly, zinc deficiency (ZD) is a common condition in elderly and individuals with chronic diseases, two groups with an increased risk for severe severe coronavirus disease 2019 (COVID-19) outcomes. We hypothesize that serum zinc content (SZC) influences COVID-19 disease progression, and thus might represent a useful biomarker. Methods: We ran an observational cohort study with 249 COVID-19 patients admitted in Hospital del Mar. We have studied COVID-19 severity and progression attending to SZC at admission. In parallel, we have studied severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) replication in the Vero E6 cell line modifying zinc concentrations. Findings: Our study demonstrates a correlation between serum zinc levels and COVID-19 outcome. Serum zinc levels lower than 50 µg/dL at admission correlated with worse clinical presentation, longer time to reach stability, and higher mortality. Our in vitro results indicate that low zinc levels favor viral expansion in SARS-CoV-2 infected cells. Interpretation: Low SZC is a risk factor that determines COVID-19 outcome. We encourage performing randomized clinical trials to study zinc supplementation as potential prophylaxis and treatment with people at risk of zinc deficiency.https://www.mdpi.com/2072-6643/13/2/562SARS-CoV-2zincclinical outcomes
collection DOAJ
language English
format Article
sources DOAJ
author Marina Vogel-González
Marc Talló-Parra
Víctor Herrera-Fernández
Gemma Pérez-Vilaró
Miguel Chillón
Xavier Nogués
Silvia Gómez-Zorrilla
Inmaculada López-Montesinos
Isabel Arnau-Barrés
Maria Luisa Sorli-Redó
Juan Pablo Horcajada
Natalia García-Giralt
Julio Pascual
Juana Díez
Rubén Vicente
Robert Güerri-Fernández
spellingShingle Marina Vogel-González
Marc Talló-Parra
Víctor Herrera-Fernández
Gemma Pérez-Vilaró
Miguel Chillón
Xavier Nogués
Silvia Gómez-Zorrilla
Inmaculada López-Montesinos
Isabel Arnau-Barrés
Maria Luisa Sorli-Redó
Juan Pablo Horcajada
Natalia García-Giralt
Julio Pascual
Juana Díez
Rubén Vicente
Robert Güerri-Fernández
Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection
Nutrients
SARS-CoV-2
zinc
clinical outcomes
author_facet Marina Vogel-González
Marc Talló-Parra
Víctor Herrera-Fernández
Gemma Pérez-Vilaró
Miguel Chillón
Xavier Nogués
Silvia Gómez-Zorrilla
Inmaculada López-Montesinos
Isabel Arnau-Barrés
Maria Luisa Sorli-Redó
Juan Pablo Horcajada
Natalia García-Giralt
Julio Pascual
Juana Díez
Rubén Vicente
Robert Güerri-Fernández
author_sort Marina Vogel-González
title Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection
title_short Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection
title_full Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection
title_fullStr Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection
title_full_unstemmed Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection
title_sort low zinc levels at admission associates with poor clinical outcomes in sars-cov-2 infection
publisher MDPI AG
series Nutrients
issn 2072-6643
publishDate 2021-02-01
description Background: Zinc is an essential micronutrient that impacts host–pathogen interplay at infection. Zinc balances immune responses, and also has a proven direct antiviral action against some viruses. Importantly, zinc deficiency (ZD) is a common condition in elderly and individuals with chronic diseases, two groups with an increased risk for severe severe coronavirus disease 2019 (COVID-19) outcomes. We hypothesize that serum zinc content (SZC) influences COVID-19 disease progression, and thus might represent a useful biomarker. Methods: We ran an observational cohort study with 249 COVID-19 patients admitted in Hospital del Mar. We have studied COVID-19 severity and progression attending to SZC at admission. In parallel, we have studied severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) replication in the Vero E6 cell line modifying zinc concentrations. Findings: Our study demonstrates a correlation between serum zinc levels and COVID-19 outcome. Serum zinc levels lower than 50 µg/dL at admission correlated with worse clinical presentation, longer time to reach stability, and higher mortality. Our in vitro results indicate that low zinc levels favor viral expansion in SARS-CoV-2 infected cells. Interpretation: Low SZC is a risk factor that determines COVID-19 outcome. We encourage performing randomized clinical trials to study zinc supplementation as potential prophylaxis and treatment with people at risk of zinc deficiency.
topic SARS-CoV-2
zinc
clinical outcomes
url https://www.mdpi.com/2072-6643/13/2/562
work_keys_str_mv AT marinavogelgonzalez lowzinclevelsatadmissionassociateswithpoorclinicaloutcomesinsarscov2infection
AT marctalloparra lowzinclevelsatadmissionassociateswithpoorclinicaloutcomesinsarscov2infection
AT victorherrerafernandez lowzinclevelsatadmissionassociateswithpoorclinicaloutcomesinsarscov2infection
AT gemmaperezvilaro lowzinclevelsatadmissionassociateswithpoorclinicaloutcomesinsarscov2infection
AT miguelchillon lowzinclevelsatadmissionassociateswithpoorclinicaloutcomesinsarscov2infection
AT xaviernogues lowzinclevelsatadmissionassociateswithpoorclinicaloutcomesinsarscov2infection
AT silviagomezzorrilla lowzinclevelsatadmissionassociateswithpoorclinicaloutcomesinsarscov2infection
AT inmaculadalopezmontesinos lowzinclevelsatadmissionassociateswithpoorclinicaloutcomesinsarscov2infection
AT isabelarnaubarres lowzinclevelsatadmissionassociateswithpoorclinicaloutcomesinsarscov2infection
AT marialuisasorliredo lowzinclevelsatadmissionassociateswithpoorclinicaloutcomesinsarscov2infection
AT juanpablohorcajada lowzinclevelsatadmissionassociateswithpoorclinicaloutcomesinsarscov2infection
AT nataliagarciagiralt lowzinclevelsatadmissionassociateswithpoorclinicaloutcomesinsarscov2infection
AT juliopascual lowzinclevelsatadmissionassociateswithpoorclinicaloutcomesinsarscov2infection
AT juanadiez lowzinclevelsatadmissionassociateswithpoorclinicaloutcomesinsarscov2infection
AT rubenvicente lowzinclevelsatadmissionassociateswithpoorclinicaloutcomesinsarscov2infection
AT robertguerrifernandez lowzinclevelsatadmissionassociateswithpoorclinicaloutcomesinsarscov2infection
_version_ 1724275939967238144